NCT04700345

Managing Non-acute Subdural Hematoma Using Liquid Materials：a Chinese Randomized Trial of MMA Treatment

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 722 (estimated)
• Sponsor: Huashan Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

MAGIC-MT study is multi-center, prospective, randomized (1:1) controlled trial designed to show that additional MMA embolization with Onyx in patients with non-acute symptomatic subdural hematoma(SDH) results in reduced hematoma recurrence in surgically treated patients/ reduced hematoma progression in conservatively managed patients.

Detailed description

The objective of this study is to show that additional MMA embolization with Onyx in patients with non-acute symptomatic subdural hematoma(SDH) results in reduced hematoma recurrence in surgically treated patients/ reduced hematoma progression in conservatively managed patients.

Conditions

• Subdural Hematoma, Non-acute

Interventions

Type	Name	Description
DEVICE	Onyx	Embolization of the Middle Meningeal Artery using the liquid embolic material
PROCEDURE	Burr-hole	Burr-hole drainage of subdural hematoma
OTHER	Medical Management	best medical management

Timeline

• Start date: 2021-03-21
• Primary completion: 2023-08-17
• Completion: 2024-06-17
• First posted: 2021-01-07
• Last updated: 2024-04-30

Locations

1 site across 1 country: China

Regulatory

• FDA-regulated device study